Tags

Type your tag names separated by a space and hit enter

Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update.
J Neurol Sci. 2014 Dec 15; 347(1-2):14-22.JN

Abstract

Hereditary motor and sensory neuropathies (HMSN) or Charcot-Marie-Tooth (CMT) diseases are the most common degenerative disorders of the peripheral nervous system. However, the frequency of the different subtypes varies within distinct populations. Although more than seventy clinical and genetic forms are known to date, more than 80% of CMT patients in Western countries have genetic abnormalities associated with PMP22, MPZ, MFN2 and GJB1. Given the considerable genetic heterogeneity of CMT, we emphasize the interest of both clinical and pathological specific features such that focused genetic testing could be performed. In this regard, peripheral nerve lesions in GDAP1 mutations (AR CMT1A), such as mitochondrial abnormalities, have been newly demonstrated. Otherwise, while demyelinating autosomal recessive CMT used to be classified as CMT4 (A, B, C …), we propose a simplified classification such as AR CMT1 (A, B, C …), and AR CMT2 for axonal forms. Also, we stress that next generation sequencing techniques, now considered to be the most efficient methods of genetic testing in CMT, will be helpful in molecular diagnosis and research of new genes involved. Finally, while no effective therapy is known to date, ongoing new therapeutic trials such as PXT3003 (a low dose combination of the three already approved drugs baclofen, naltrexone, and D-sorbitol) give hopes for potential curative treatment.

Authors+Show Affiliations

Department of Neurology, University Hospital Mustapha Bacha, Algiers, Algeria; Laboratoire de Neurosciences, University of Algiers 1, Algiers, Algeria. Electronic address: meriem.tazir@sante.dz.Laboratoire de Neurosciences, University of Algiers 1, Algiers, Algeria; Laboratoire de Biologie Moléculaire, University of Boumerdes, Boumerdes, Algeria.Department of Neurology, University Hospital Mustapha Bacha, Algiers, Algeria; Laboratoire de Neurosciences, University of Algiers 1, Algiers, Algeria.Department of Neurology, CHU Poitiers, University of Poitiers, France.Centre de Référence Neuropathies Périphériques Rares, Service et Laboratoire de Neurologie, University Hospital, Limoges, France.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

25454638

Citation

Tazir, Meriem, et al. "Hereditary Motor and Sensory Neuropathies or Charcot-Marie-Tooth Diseases: an Update." Journal of the Neurological Sciences, vol. 347, no. 1-2, 2014, pp. 14-22.
Tazir M, Hamadouche T, Nouioua S, et al. Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update. J Neurol Sci. 2014;347(1-2):14-22.
Tazir, M., Hamadouche, T., Nouioua, S., Mathis, S., & Vallat, J. M. (2014). Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update. Journal of the Neurological Sciences, 347(1-2), 14-22. https://doi.org/10.1016/j.jns.2014.10.013
Tazir M, et al. Hereditary Motor and Sensory Neuropathies or Charcot-Marie-Tooth Diseases: an Update. J Neurol Sci. 2014 Dec 15;347(1-2):14-22. PubMed PMID: 25454638.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update. AU - Tazir,Meriem, AU - Hamadouche,Tarik, AU - Nouioua,Sonia, AU - Mathis,Stephane, AU - Vallat,Jean-Michel, Y1 - 2014/10/16/ PY - 2014/06/05/received PY - 2014/10/06/revised PY - 2014/10/08/accepted PY - 2014/12/3/entrez PY - 2014/12/3/pubmed PY - 2015/8/8/medline KW - AR CMT1 KW - AR CMT2 KW - Charcot–Marie–Tooth disease (CMT) KW - HMSN KW - NGS KW - PXT3003 trial SP - 14 EP - 22 JF - Journal of the neurological sciences JO - J Neurol Sci VL - 347 IS - 1-2 N2 - Hereditary motor and sensory neuropathies (HMSN) or Charcot-Marie-Tooth (CMT) diseases are the most common degenerative disorders of the peripheral nervous system. However, the frequency of the different subtypes varies within distinct populations. Although more than seventy clinical and genetic forms are known to date, more than 80% of CMT patients in Western countries have genetic abnormalities associated with PMP22, MPZ, MFN2 and GJB1. Given the considerable genetic heterogeneity of CMT, we emphasize the interest of both clinical and pathological specific features such that focused genetic testing could be performed. In this regard, peripheral nerve lesions in GDAP1 mutations (AR CMT1A), such as mitochondrial abnormalities, have been newly demonstrated. Otherwise, while demyelinating autosomal recessive CMT used to be classified as CMT4 (A, B, C …), we propose a simplified classification such as AR CMT1 (A, B, C …), and AR CMT2 for axonal forms. Also, we stress that next generation sequencing techniques, now considered to be the most efficient methods of genetic testing in CMT, will be helpful in molecular diagnosis and research of new genes involved. Finally, while no effective therapy is known to date, ongoing new therapeutic trials such as PXT3003 (a low dose combination of the three already approved drugs baclofen, naltrexone, and D-sorbitol) give hopes for potential curative treatment. SN - 1878-5883 UR - https://www.unboundmedicine.com/medline/citation/25454638/Hereditary_motor_and_sensory_neuropathies_or_Charcot_Marie_Tooth_diseases:_an_update_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0022-510X(14)00666-2 DB - PRIME DP - Unbound Medicine ER -